The objective of the infectious diseases clinic at the Institut Jules Bordet is to prevent and treat the infectious complications occurring in cancer patients, whether they are connected with the cancer itself or with its treatment (chemotherapy, radiotherapy, surgery, etc.)
- Prevention and antibiotic treatments of infections in close collaboration with all the other doctors of the Institute
- Management of febrile neutropenia which can occur after chemotherapy
- Prevention and treatment of infectious complications after haematopoietic stem cell transplantation
The Infectious Diseases Department takes part in interuniversity courses on infectious diseases. This semiology course is given to medical students and also forms part of a series of training sessions intended for doctors in training at the Institut Jules Bordet.
Research projects
Project 1
Role of monitoring smears in detecting patients colonised with resistant bacteria in neutropenic patients and their impact on empirical treatments in the case of febrile neutropenia.
- Project leader : Dr Georgala
- Collaboration : Labo CHU Saint-Pierre (Mrs Miendje and Mrs Martiny)
- Financing : Les Amis de l’Institut Bordet
Project 2
Epidemiology of invasive fungal infections
- Project leader : Dr Mickael Aoun
- Collaboration : Marianne Paesmans (UGI)
- Financing : /
Projet 3
Fever of undetermined origin: role of PETscan
- Project leader : Dr Angela Loizidou
- Collaboration : Marianne Paesmans (UGI), Department of Nuclear Medicine
Our team
Head of Clinic
Dr Aspasia Georgala
(Secretary : Nathalie Cardinal)
Head of Clinic adjunct
Dr Angela Loizidou
Dr Michaela Raimo
Team
Dr Michaela Raimo
Vanessa Coubeaux (research nurse)
05/01/2022
Scientific publications
Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow.
Authors : Cupaiolo R, Cherkaoui S, Serrano G, Dauby N, Georgala A, Blumental S, Maillart E, Hites M, Hallin M, Martiny D
Year : 2022
Journal : J Microbiol Methods
Volume : 194
Pages : 106433
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.
Authors : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M
Year : 2022
Journal : Diagnostics (Basel)
Volume : 12
COVID-19 Sequelae and the Host Pro-Inflammatory Response: An Analysis From the OnCovid Registry.
Authors : Cortellini A, Gennari A, Pommeret F, Patel G, Newsom-Davis T, Bertuzzi A, Viladot M, Aguilar-Company J, Mirallas O, Felip E, Lee AJX, Pria AD, Sharkey R, Brunet J, Garcia MC, Chester J, Mukherjee U, Scotti L, Dolly S, Sita-Lumsden A, Ferrante D, Van Hemelrijck M, Moss C, Russell B, Seguí E, Biello F, Krengli M, Marco-Hernández J, Gaidano G, Patriarca A, Bruna R, Roldán E, Fox L, Pous A, Griscelli F, Salazar R, Martinez-Vila C, Sureda A, Loizidou A, Maluquer C, Stoclin A, Iglesias M, Pedrazzoli P, Rizzo G, Santoro A, Rimassa L, Rossi S, Harbeck N, de Torre AS, Vincenzi B, Libertini M, Provenzano S, Generali D, Grisanti S, Berardi R, Tucci M, Mazzoni F, Lambertini M, Tagliamento M, Parisi A, Zoratto F, Queirolo P, Giusti R, Guida A, Zambelli A, Tondini C, Maconi A, Betti M, Colomba E, Diamantis N, Sinclair A, Bower M, Ruiz-Camps I, Pinato DJ
Year : 2022
Journal : J Natl Cancer Inst
PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.
Authors : Gueuning C, Ameye L, Loizidou A, Grigoriu B, Meert AP
Year : 2022
Journal : Support Care Cancer
Volume : 30
Pages : 7635-7643
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.
Authors : Martins-Branco D, Nader-Marta G, Tecic Vuger A, Debien V, Ameye L, Brandão M, Punie K, Loizidou A, Willard-Gallo K, Spilleboudt C, Awada A, Piccart M, de Azambuja E
Year : 2022
Journal : J Cancer Res Clin Oncol
Pages : 1-6